⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CVRX News
CVRx, Inc. Common Stock
CVRx to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call on February 12, 2026
globenewswire.com
CVRX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX
prnewswire.com
CVRX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX
accessnewswire.com
CVRX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of CVRx, Inc. – CVRX
globenewswire.com
CVRX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX
accessnewswire.com
CVRX
CVRx Announces Initiation of BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population
globenewswire.com
CVRX
Wolf Popper LLP Announces Investigation on Behalf of CVRx, Inc. Investors
globenewswire.com
CVRX
Anumana Appoints Kevin Ballinger and Jean-Luc Butel to Board of Directors
businesswire.com
CVRX
TAK
ICON
RANI
BAX
MDT
BDX
JNJ
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2025 Financial Results and Issues Fiscal 2026 Guidance
globenewswire.com
CVRX
CVRx Announces Implementation of New Category I CPT Codes for Barostim Therapy
globenewswire.com
CVRX